About the Gout Working Group

Gout is the most common form of inflammatory arthritis and is caused by deposition of monosodium urate (MSU) crystals in and around joints, which provokes an intense inflammatory response. Gout manifests as episodes of intense joint pain, swelling, and functional disability that may lead to persistent joint symptoms and structural joint damage. At Outcome Measures in Rheumatology (OMERACT) meetings, joint damage imaging has been endorsed as a discretionary domain for outcome measurement in chronic gout studies. However, no specific imaging instruments have been endorsed by OMERACT for use in gout studies. In the last decade there have been major advances in imaging in gout and so it was appropriate that the OMERACT gout working group focused on imaging modalities as outcome measures for use in chronic gout studies.

nicola

Nicola Dalbeth

Co-Chair

Jasvinder-A-Singh-Final

Jasvinder A. Singh

Co-Chair

Screen Shot 2022-08-14 at 5.11.20 PM

Will Taylor

Co-Chair

ENDORSED DOMAINS FOR ACUTE GOUT

Screen Shot 2022-08-14 at 5.48.51 PM

ENDORSED DOMAINS FOR CHRONIC GOUT

Screen Shot 2022-08-14 at 5.49.05 PM

Working Group Members:

Rebecca Grainger
Cesar Diaz-Torne
Nicola Dalbeth
Laura Durcan
N. Lawrence Edwards

Helen Keen
Dinesh Khanna
Fernando Perez-Ruiz
Lee S. Simon
Jasvinder A. Singh
William J. Taylor
Peter Tugwell

Scroll to Top